Medicure is committed to maintaining the highest level of integrity and ethical responsibility. We believe that these values start with strong leadership. Our management team is led by a multidisciplinary group of highly educated leaders that have significant experience in pharmaceutical product development and commercialization.
President & Chief Executive Officer
holds a Ph.D. in protein chemistry from the University of Manitoba. He has been instrumental in the founding and development of several health industry companies, including ABI Biotechnology (now Apotex Fermentation), Canada's first profitable biotech company, and the Winnipeg Rh Institute, where he led the development of Canada's first biotech product, WinRho. Dr. Friesen has also played a key role in a number of regional and national organizations, including a founder and first Board of Director Chair of the Industrial Biotechnology Association of Canada (now BIOTECanada). He is President and founder of Genesys Venture Inc. (GVI), which provides the expertise for launching and managing emerging health and biotechnology ventures. He has served as CEO and Chair of Medicure Inc. since he led its formation in 1997.
Chief Financial Officer
Mr. Kinley is responsible for the financial operations of Medicure through its contract with Genesys Venture, Inc. Previously, Mr. Kinley was Manager, Financial Reporting at Manitoba Telecom Services Ltd. (MTS). His responsibilities included the review and distribution of external quarterly and annual financial statements, internal financial statements and board reporting packages. He was also significantly involved in the conversion from Canadian Generally Accepted Accounting Principles (GAAP) to International Financial Reporting Standards (IFRS). Mr.Kinley has extensive experience working with publicaly traded entities, having provided financial reporting services for a number of stock exchange listed real estate investment trusts (REITs) from 2006 to 2008. Prior to this time he was an Audit Senior at Ernst & Young, LLP. Mr Kinley is a Chartered Accountant and holds a B.Comm (Honours) degree from the I.H. Asper School of Business (University of Manitoba).
joined Medicure in 2007 as an analyst in business development and commercial operations. He was soon promoted to Manager of Commercial Operations for AGGRASTAT®, and eventually named Director. Since 2013, Graeme has been Vice President of Commercial Operations. He is responsible for all sales, marketing, and medical activities for AGGRASTAT within the United States. Graeme was instrumental in helping guide Medicure through its corporate restructuring and the relaunch of AGGRASTAT under the FDA approved High-Dose Bolus (HDB) regimen. He has a B.B.A. from the University of New Brunswick with a specialization in finance.